banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4

Verve Therapeutics: A New Era in Cardiovascular Disease Treatment?

In a major breakthrough, Verve Therapeutics (VERV) has announced positive results from its Heart-2 clinical trial. This news sent shockwaves through the market, with shares surging by over 21% today. So what does this mean for investors? And is Verve Therapeutics a stock to watch? What’s Going On Here Imagine your body as a car … Read more

Novo Nordisk’s diabetes pill Rybelsus slashes cardiovascular risk

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with diabetes and heart disease.  The pill lowered the risk of cardiovascular-related death, heart attack and stroke by 14% compared to a placebo after four … Read more

banner banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4